Patient engagement reaches the C-suite
In less than a decade, the chief patient officer - and similar roles with different titles - has become a key part of the healthcare industry executive team.
How about this obnoxious germ alarm as a reminder for workers to wash their hands?
Safeguard, Procter & Gamble’s largest global personal care brand, has created a seriously loud handwashing reminder in a bid to keep people using public bathrooms from spreading so many germs. It’s a soap dispenser rigged with an alarm. Pressure sensors placed on doors connect back to the dispenser/alarm, and when someone tries to open the […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Venture firms bet $41M more on P&G spinout developing oral anemia drug
Akebia Therapeutics might be a bit behind in the race to develop a safer, oral drug for anemia, but it’s just gotten a big vote of confidence from investors in the form of a $41 million Series C. Novartis Venture Fund, Kearny Venture Partners, Venture Investors LLC, Athenian Venture Partners, Triathlon Medical Ventures, AgeChem Venture […]
Procter & Gamble to promote insomnia drug from Somaxon
The deal with Somaxon is P&G's only one in which its sales reps promote a prescription drug developed by another company.
Akebia begins Phase 2a trial of oral anemia drug
Akebia Therapeutics Inc. has begun a Phase 2a clinical trial of its orally administered anemia drug. The company recently completed a Phase 1b trial of the drug, called AKB-6548, that showed an increase in erythropoietin, immature red blood cells and hemoglobin with “no significant adverse events,” according to a statement from the Cincinnati-area drug developer. […]
Ohio drug, therapy companies share limelight at BIO convention
The Biotechnology Industry Organization international convention returns to Chicago this week — a nod to the importance of pharmaceutical and therapeutic companies in Midwestern states like Ohio. Drugmaking has history in Ohio. From Procter & Gamble Pharmaceuticals (NYSE: PG) in Cincinnati (sold last year to Irish drug company Warner Chilcott), to generic drugmakers Ben Venue […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Blue Ash Therapeutics raises $2M-plus to push drug over finish line
Blue Ash Therapeutics has raised more than $2 million to help push its first and only drug across the regulatory finish line with a pivotal clinical trial. Started more than a year ago by pharmaceutical industry veterans Greg Flexter and Kevin Malloy, the Cincinnati company is finishing development of Azimilide, a drug that can work […]
Ohio universities, Procter & Gamble to speed ideas to market
The University System of Ohio’s 14 universities and consumer product giant Procter & Gamble (NYSE: PG) in Cincinnati have agreed to simplify the legal process of negotiating joint research projects with the intent of bringing ideas to market faster. Having a master contract to which a project’s unique terms could be added is expected to […]
Warner Chilcott to shut former P&G pharma office; 250 jobs gone
The Irish company that acquired Procter & Gamble Co.‘s pharmaceutical division last year is shutting its Mason, Ohio, office to boost its operational effectiveness, cutting about 250 jobs, according to the Cincinnati Enquirer. Warner Chilcott plc plans to consolidate the work done in Mason at its U.S. headquarters in Rockaway, N. J., according to an […]
Night Read (Ohio): Tennessee hospital looks to buy Forum Health?
A sale of Youngstown's Forum Health, which is reorganizing under Chapter 11 bankruptcy protection, to Nashville, Tenn., hospital system Ardent Health Services hinges on successful negotiations with unions representing about 3,500 Forum workers, unnamed sources told the Tribune Chronicle.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Gov. Ted Strickland: ‘I believe in Ohio’
Ohio Gov. Ted Strickland did not mention the terms "biomedical" or "health care" in his State of the State address at noon today. However, Strickland did announce several business investment, research and worker-training programs that could help companies in these industries grow and create jobs.
Prilosec OTC wants to help you enjoy your passions — MedCity Evening Read, Jan. 6, 2010
Prilosec OTC today launched the "Official Sponsor of Everything You Do Without Heartburn" program to help consumers enjoy their passions (excluding heartburn).
Cleveland Clinic gets grants, license agreement, invests in digital medicine — MedCity Evening Read, Dec. 8, 2009
The Cleveland Clinic has received a $2.75 million federal grant to study the use of stem cells in treating multiple sclerosis, received a grant of more than $123,000 from NFL Charities to explore treatments for shoulder instability, licensed a system to replace damaged or severed mitral valve chordae in the heart and invested $100 million in digital record-keeping.
P & G leaves prescription drugs: What (people think) it all means
Read through the additional details, predictions and pontifications beyond the fact Irish drugmaker Warner Chilcott purchased Procter & Gamble's prescription drug unit for $3.1 billion.
The costs of pharmaceuticals changed. For P&G, the price was too high
P & G is selling a pharmaceutical line that had revenue of $2.3 billion last year and net income of approximately $540 million for the year ended June 30. But the economic landscape was much different when the company launched a segment away from its consumer products holdings.